<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

Join global life science investors 

Qualified investors can attend for free. Please check qualifying T&Cs before you register

DOWNLOAD BROCHURE

BOOK TICKETS

Qualified investors attend for free

Qualified investors include:

  1. Senior management or investment staff with a Fund (ETF, mutual fund, or other non- bank institution) currently invested in life sciences.
  2. Senior management or investment staff from a pension or employee benefit plan currently invested in life sciences.
  3. Senior management at a family office currently or previously invested in life sciences.
  4. Senior leadership or management with a venture or private equity firm managing assets of $25 million or more.
  5. Senior management at an angel investor fund (or group) currently or previously invested in life sciences. Not individual Angels.
  6. Senior management at a charitable or not-for-profit organization with a fund of $5 million or more currently invested in the life sciences.
  7. Research Analyst for a fund currently invested in UK/EU/US/Asian life science companies.

An investor who receives complimentary registration is expected to participate in the One- on-One Partnering, with at least five meetings secured through the system with life science companies.

Attendees who do not qualify for complimentary registration include:

  1. Executives who invest personal, disposable income, who's salaried occupation is not that of a full time investor (i.e. not individual Angels)
  2. Firms who offer advisory or consulting services of any nature.
  3. Firms who offer brokerage services of any nature.
  4. Crowd funding platforms. 
  5. Service providers/consultants to the biotech industry.
  6. Biotech/ life sciences company employee or product suppliers to the biotech industry including CRO’s and CMO’s.
  7. Firms that provide services and/or charge a fee to biotech companies in exchange for research/media/investor relations coverage.
  8. Retail/individual investors.
  9. Investment and merchant bankers.
  10. Real estate development professionals.
  11. Members of economic development organisations.
  12. Firms who have a service providing component to their fund’s business model will be evaluated on a case by case basis. If this fund’s information is NOT located in any mainstream database (Ipreo, FactSet), LSX may ask for references for investor qualification.

LSX reserves the right, in its sole discretion, to make the determination of the proper classification of an investor or registrant. Depending on this classification, registration fees may be required.

LSX reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.

If you have any questions please contact steph@lsxleaders.com.  


A snapshot of our past investors

4bio Capital Logo
7wireVentures Logo
Abingworth Logo
Ackermans & van Haaren
Albion Capital Logo
Alpha Blue Ocean Logo
Alsa
Apollo Health Ventures Logo
Apple Tree Partners Logo
Arena Investors Logo
Asabys Partners
Astia Inc Logo
AXA IM Logo
Axilium Capital 300x150
Bain Capital 300x-1
BioGeneration Ventures Logo
Blackstone Life Sciences Logo
Brightcap Ventures Logo
British Patient Capital
Cambridge Innovation Capital 300x150
Chemovator
Claret Capital Partners
Claris Ventures 300x150
Clavis Capital Logo
Club degli Investitori
Debiopharm Group Logo
Deep Science Ventures Logo
Deerfield_Management
Destiny Pharma
Dhenin
Earlybird Venture Capital Logo
Endeavour Vision Logo
Enterprise Ireland Logo
Epidarex Capital Logo
Flagship Pioneering Logo
Flare Capital Partners Logo
Forbion Capital
GGS Associates Logo
Global Brain Logo
Goddess Gaia Ventures
GP Bullhound
Hadean Ventures Logo
Heal Capital 300x
Health Capital Helsinki 300x
Heran Partners Logo
High-Tech Gruenderfonds Logo
Hikma Ventures Logo
HLM Venture Partners Logo
Hogan Lovells 300x200
HKSTP Logo
i-expand Logo
In-Q-Tel, Inc. Logo
Indaco Venture Partners Logo
INKEF Capital Logo
Innogest SGR 300x150
Intuitive Surgical 300x
Innovestor Ventures-1
Inveready Logo
IP Group Logo
JUSTLY MARKETS Logo
Kissei America Logo
Karista Logo
Lauxera Capital Partners 300x
LifeArc Ventures Logo
LSP Logo
Longliv Ventures 300x
Longwall Venture Partners Logo
LSV Capital Logo
LucidQuest Ventures 300x
Lynx Financial Logo
M. Ventures-1
M&G Logo
MARCOL Logo
Marwood Group
Mayewell Capital
Melior Capital Management Logo
Mercia Asset Management 300x150
Molten Ventures
MTIP Logo
Nextech 300x
Nina Capital Logo
nlc.health Logo
Norgine Ventures Logo
Novalis Logo
Novateur Ventures Logo
Novo Ventures Logo
Octopus Ventures Logo
OMERS Ventures Logo
Optum Ventures Logo
OrbiMed Advisors Logo
OXFORD SCIENCES INNOVATION PLC Logo
Panakes Partners Logo
Partners Group Logo
Pivotal life Sciences
Plug and Play Logo
Polar Capital 300x
Population Health Partners
Preclin Biosystems
RA Capital Management LLC Logo
Raglan Capital Logo
Redalpine-2
Rhia Ventures Logo
River BioMedics
RTW Investments Logo
RYSE Asset Management
Seroba+Logo+Small+Digital+Use
SHS Capital Logo
Sofinnova Partners Logo
Softbank Vision Fund Logo
SR One Logo
Start Codon Logo
SV Health Investors Logo
Syncona Logo
Tandem Ventures 300x
TVM Capital Logo
Wellington Partners Logo
What If Venture

DOWNLOAD BROCHURE